A Case of Primary Plasmacytoma of Lymph Nodes

Young Hyo Lim(Hanyang University), In Soon Kim(Hanyang University), Jung Hye Choi(Hanyang University Guri Hospital), Young Yul Lee(Hanyang University), Ho Suk Oh(Hanyang University), Myung‐Ju Ahn(Sungkyunkwan University), Su Kyoung Park(Hanyang University)

The Korean Journal of Internal Medicine

January 1, 2005

10.3904/kjim.2005.20.2.183

Cited by 17

Related Papers

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

|New England Journal of Medicine|2013|3.4k

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

|The Lancet|2019|3.4k

Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer

|New England Journal of Medicine|2016|3.3k

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

|The Lancet|2018|1.7k

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

|The Lancet Oncology|2019|537